Click on the links below to view Kaisha Lifescience's media coverages, press releases, and company brochure.
Vaccine manufacturers and ancillaries are anticipating a strong demand from the government for Covid-19 vaccines.
Indian drug vial maker Schott Kaisha is expecting annual vial sales for COVID-19 shots to more than triple as vaccine production.
The surge in demand for medicines to treat Covid-19 has been intense and with life-and-death consequences for patients.
Serum Institute has acquired stake from former co-owners Kairus Dadachanji and Shapoor Mistry.